华绿生物(300970.SZ)发预盈，预计2025年归母净利润1亿元至1.3亿元，扭亏为盈

Core Viewpoint - Hualu Bio (300970.SZ) expects to achieve a net profit attributable to shareholders of 100 million to 130 million yuan for the fiscal year 2025, marking a turnaround from losses to profitability [1] Financial Performance - The company anticipates a net profit of 100 million to 130 million yuan after deducting non-recurring gains and losses, indicating a significant improvement in financial health [1] - The increase in performance is primarily attributed to a simultaneous rise in both sales prices and sales volumes [1]